{"count":9,"next":null,"previous":null,"results":[{"gene_data":{"alias":["AGXT1","PH1","AGT","SPT","AGT1"],"biotype":"protein_coding","hgnc_id":"HGNC:341","gene_name":"alanine-glyoxylate aminotransferase","omim_gene":["604285"],"alias_name":["oxalosis I","primary hyperoxaluria type 1","L-alanine: glyoxylate aminotransferase 1","serine:pyruvate aminotransferase","glycolicaciduria"],"gene_symbol":"AGXT","hgnc_symbol":"AGXT","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"2:241807896-241819919","ensembl_id":"ENSG00000172482"}},"GRch38":{"90":{"location":"2:240868479-240880502","ensembl_id":"ENSG00000172482"}}},"hgnc_date_symbol_changed":"1990-11-20"},"entity_type":"gene","entity_name":"AGXT","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Green","Emory Genetics Laboratory","Radboud University Medical Center, Nijmegen","UKGTN","Illumina TruGenome Clinical Sequencing Services"],"phenotypes":["Hyperoxaluria, primary, type 1\t259900"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":114,"hash_id":"57b6f5058f6203767a308772","name":"Peroxisomal disorders","disease_group":"Metabolic disorders","disease_sub_group":"Peroxisomal disorders","status":"public","version":"1.6","version_created":"2017-11-05T02:37:20.056128Z","relevant_disorders":["Other peroxisomal disorders","Peroxisomal biogenesis disorders"],"stats":{"number_of_genes":37,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["AGXT1","PH1","AGT","SPT","AGT1"],"biotype":"protein_coding","hgnc_id":"HGNC:341","gene_name":"alanine-glyoxylate aminotransferase","omim_gene":["604285"],"alias_name":["oxalosis I","primary hyperoxaluria type 1","L-alanine: glyoxylate aminotransferase 1","serine:pyruvate aminotransferase","glycolicaciduria"],"gene_symbol":"AGXT","hgnc_symbol":"AGXT","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"2:241807896-241819919","ensembl_id":"ENSG00000172482"}},"GRch38":{"90":{"location":"2:240868479-240880502","ensembl_id":"ENSG00000172482"}}},"hgnc_date_symbol_changed":"1990-11-20"},"entity_type":"gene","entity_name":"AGXT","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Green","Eligibility statement prior genetic testing","Expert","Radboud University Medical Center, Nijmegen","Illumina TruGenome Clinical Sequencing Services","UKGTN","Emory Genetics Laboratory"],"phenotypes":["Primary Hyperoxaluria Type 1","Primary Hyperoxaluria","Hyperoxaluria, primary, type 1, 259900","Hyperoxaluria","primary hyperoxaluria"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":149,"hash_id":"553f94d5bb5a1616e5ed45a5","name":"Nephrocalcinosis or nephrolithiasis","disease_group":"Renal and urinary tract disorders","disease_sub_group":"Disorders of function","status":"public","version":"1.18","version_created":"2019-09-17T20:55:27.132282Z","relevant_disorders":["Renal tract calcification (or Nephrolithiasis or nephrocalcinosis)","Renal tract calcification (or Nephrolithiasis/nephrocalcinosis)","R256"],"stats":{"number_of_genes":42,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"},{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"}]}},{"gene_data":{"alias":["AGXT1","PH1","AGT","SPT","AGT1"],"biotype":"protein_coding","hgnc_id":"HGNC:341","gene_name":"alanine-glyoxylate aminotransferase","omim_gene":["604285"],"alias_name":["oxalosis I","primary hyperoxaluria type 1","L-alanine: glyoxylate aminotransferase 1","serine:pyruvate aminotransferase","glycolicaciduria"],"gene_symbol":"AGXT","hgnc_symbol":"AGXT","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"2:241807896-241819919","ensembl_id":"ENSG00000172482"}},"GRch38":{"90":{"location":"2:240868479-240880502","ensembl_id":"ENSG00000172482"}}},"hgnc_date_symbol_changed":"1990-11-20"},"entity_type":"gene","entity_name":"AGXT","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Green","NHS GMS"],"phenotypes":["Hyperoxaluria, primary, type 1, 259900","Primary Hyperoxaluria","Hyperoxaluria","primary hyperoxaluria","Primary Hyperoxaluria Type 1"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":678,"hash_id":null,"name":"Unexplained paediatric onset end-stage renal disease","disease_group":"","disease_sub_group":"","status":"public","version":"0.43","version_created":"2019-09-25T12:25:36.245604Z","relevant_disorders":["R257"],"stats":{"number_of_genes":229,"number_of_strs":0,"number_of_regions":3},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"}]}},{"gene_data":{"alias":["AGXT1","PH1","AGT","SPT","AGT1"],"biotype":"protein_coding","hgnc_id":"HGNC:341","gene_name":"alanine-glyoxylate aminotransferase","omim_gene":["604285"],"alias_name":["oxalosis I","primary hyperoxaluria type 1","L-alanine: glyoxylate aminotransferase 1","serine:pyruvate aminotransferase","glycolicaciduria"],"gene_symbol":"AGXT","hgnc_symbol":"AGXT","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"2:241807896-241819919","ensembl_id":"ENSG00000172482"}},"GRch38":{"90":{"location":"2:240868479-240880502","ensembl_id":"ENSG00000172482"}}},"hgnc_date_symbol_changed":"1990-11-20"},"entity_type":"gene","entity_name":"AGXT","confidence_level":"3","penetrance":"Complete","mode_of_pathogenicity":"","publications":["27604308"],"evidence":["Expert Review Green","Literature"],"phenotypes":["Primary hyperoxaluria type I (Disorders of glyoxylate metabolism)","Primary hyperoxaluria type I (Other peroxisomal disorders)","Hyperoxaluria, primary, type 1"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":302,"hash_id":"5763f1518f620350a22bccdb","name":"Undiagnosed metabolic disorders","disease_group":"Metabolic disorders","disease_sub_group":"Specific metabolic abnormalities","status":"public","version":"1.373","version_created":"2019-10-08T14:47:17.153678Z","relevant_disorders":["Undiagnosed Metabolic Panel"],"stats":{"number_of_genes":744,"number_of_strs":1,"number_of_regions":1},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"}]}},{"gene_data":{"alias":["AGXT1","PH1","AGT","SPT","AGT1"],"biotype":"protein_coding","hgnc_id":"HGNC:341","gene_name":"alanine-glyoxylate aminotransferase","omim_gene":["604285"],"alias_name":["oxalosis I","primary hyperoxaluria type 1","L-alanine: glyoxylate aminotransferase 1","serine:pyruvate aminotransferase","glycolicaciduria"],"gene_symbol":"AGXT","hgnc_symbol":"AGXT","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"2:241807896-241819919","ensembl_id":"ENSG00000172482"}},"GRch38":{"90":{"location":"2:240868479-240880502","ensembl_id":"ENSG00000172482"}}},"hgnc_date_symbol_changed":"1990-11-20"},"entity_type":"gene","entity_name":"AGXT","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["27604308"],"evidence":["London North GLH","NHS GMS","Expert Review Green"],"phenotypes":["Primary hyperoxaluria type I (Other peroxisomal disorders)","Primary hyperoxaluria type I (Disorders of glyoxylate metabolism)","Hyperoxaluria, primary, type 1"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":467,"hash_id":null,"name":"Inborn errors of metabolism","disease_group":"","disease_sub_group":"","status":"public","version":"1.348","version_created":"2019-10-09T08:19:52.386941Z","relevant_disorders":["Likely inborn error of metabolism - targeted testing not possible"],"stats":{"number_of_genes":877,"number_of_strs":2,"number_of_regions":1},"types":[{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}},{"gene_data":{"alias":["AGXT1","PH1","AGT","SPT","AGT1"],"biotype":"protein_coding","hgnc_id":"HGNC:341","gene_name":"alanine-glyoxylate aminotransferase","omim_gene":["604285"],"alias_name":["oxalosis I","primary hyperoxaluria type 1","L-alanine: glyoxylate aminotransferase 1","serine:pyruvate aminotransferase","glycolicaciduria"],"gene_symbol":"AGXT","hgnc_symbol":"AGXT","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"2:241807896-241819919","ensembl_id":"ENSG00000172482"}},"GRch38":{"90":{"location":"2:240868479-240880502","ensembl_id":"ENSG00000172482"}}},"hgnc_date_symbol_changed":"1990-11-20"},"entity_type":"gene","entity_name":"AGXT","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Red","PAGE DD-Gene2Phenotype"],"phenotypes":["HYPEROXALURIA, PRIMARY, TYPE 1"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":478,"hash_id":null,"name":"Fetal anomalies","disease_group":"","disease_sub_group":"","status":"public","version":"0.344","version_created":"2019-09-17T09:38:10.568007Z","relevant_disorders":["R21"],"stats":{"number_of_genes":1721,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."}]}},{"gene_data":{"alias":["AGXT1","PH1","AGT","SPT","AGT1"],"biotype":"protein_coding","hgnc_id":"HGNC:341","gene_name":"alanine-glyoxylate aminotransferase","omim_gene":["604285"],"alias_name":["oxalosis I","primary hyperoxaluria type 1","L-alanine: glyoxylate aminotransferase 1","serine:pyruvate aminotransferase","glycolicaciduria"],"gene_symbol":"AGXT","hgnc_symbol":"AGXT","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"2:241807896-241819919","ensembl_id":"ENSG00000172482"}},"GRch38":{"90":{"location":"2:240868479-240880502","ensembl_id":"ENSG00000172482"}}},"hgnc_date_symbol_changed":"1990-11-20"},"entity_type":"gene","entity_name":"AGXT","confidence_level":"3","penetrance":null,"mode_of_pathogenicity":"","publications":["8101040"],"evidence":["Expert Review Green","DD-Gene2Phenotype"],"phenotypes":["HYPEROXALURIA, PRIMARY, TYPE 1 259900"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":484,"hash_id":null,"name":"DDG2P","disease_group":"","disease_sub_group":"","status":"public","version":"1.137","version_created":"2019-10-08T15:56:59.220133Z","relevant_disorders":[],"stats":{"number_of_genes":1893,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}},{"gene_data":{"alias":["AGXT1","PH1","AGT","SPT","AGT1"],"biotype":"protein_coding","hgnc_id":"HGNC:341","gene_name":"alanine-glyoxylate aminotransferase","omim_gene":["604285"],"alias_name":["oxalosis I","primary hyperoxaluria type 1","L-alanine: glyoxylate aminotransferase 1","serine:pyruvate aminotransferase","glycolicaciduria"],"gene_symbol":"AGXT","hgnc_symbol":"AGXT","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"2:241807896-241819919","ensembl_id":"ENSG00000172482"}},"GRch38":{"90":{"location":"2:240868479-240880502","ensembl_id":"ENSG00000172482"}}},"hgnc_date_symbol_changed":"1990-11-20"},"entity_type":"gene","entity_name":"AGXT","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"","publications":["4701948","25363903"],"evidence":["NHS GMS","London North GLH"],"phenotypes":["Hyperoxaluria, primary, type 1, 259900","Renal failure and deposition of calcium oxalate crystals in tissues including nerve and muscle. Sensory and motor axonal neuropathy (some slowing)"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":85,"hash_id":"55ad205422c1fc7041340234","name":"Hereditary neuropathy","disease_group":"Neurology and neurodevelopmental disorders","disease_sub_group":"Motor and Sensory Disorders of the PNS","status":"public","version":"1.333","version_created":"2019-07-09T13:10:50.031506Z","relevant_disorders":["Charcot-Marie-Tooth disease"],"stats":{"number_of_genes":276,"number_of_strs":11,"number_of_regions":2},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"},{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."}]}},{"gene_data":{"alias":["AGXT1","PH1","AGT","SPT","AGT1"],"biotype":"protein_coding","hgnc_id":"HGNC:341","gene_name":"alanine-glyoxylate aminotransferase","omim_gene":["604285"],"alias_name":["oxalosis I","primary hyperoxaluria type 1","L-alanine: glyoxylate aminotransferase 1","serine:pyruvate aminotransferase","glycolicaciduria"],"gene_symbol":"AGXT","hgnc_symbol":"AGXT","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"2:241807896-241819919","ensembl_id":"ENSG00000172482"}},"GRch38":{"90":{"location":"2:240868479-240880502","ensembl_id":"ENSG00000172482"}}},"hgnc_date_symbol_changed":"1990-11-20"},"entity_type":"gene","entity_name":"AGXT","confidence_level":"2","penetrance":"Complete","mode_of_pathogenicity":"","publications":[],"evidence":["Expert Review Amber","BRIDGE study SPEED NEURO Tier1 Gene"],"phenotypes":["Hyperoxaluria, primary, type 1, 259900"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":285,"hash_id":"558aa423bb5a16630e15b63c","name":"Intellectual disability","disease_group":"Neurology and neurodevelopmental disorders","disease_sub_group":"Neurodevelopmental disorders","status":"public","version":"2.1065","version_created":"2019-10-07T13:42:16.019766Z","relevant_disorders":["Coarse facial features including Coffin-Siris-like disorders","ID","Moderate","severe or profound intellectual disability","Schizophrenia plus additional features","Intellectual disability - microarray","fragile X and sequencing"],"stats":{"number_of_genes":2253,"number_of_strs":11,"number_of_regions":57},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"},{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}}]}